容积导航技术用于仅MRI检出的乳腺病灶超声引导活检
研究纳入13个月内22例26个MRI检出但二次超声未发现的BI-RADS 4或5类乳腺病灶,采用3-T MRI快速序列和体线圈重新成像,将MRI容积数据与实时超声配准后行VNT引导活检。病理显示18个良性、6个恶性,另2个高危病灶切除后升级为癌;56%良性病灶在随访MRI消失。作者认为VNT是超声隐匿性乳腺病灶MRI引导活检的可行替代方案。
要点
- VNT可将MRI容积数据与实时超声配准,实现仅MRI检出乳腺病灶的超声定位。
- 26个病灶中11个经VNT引导超声检出后直接活检,15个仍超声隐匿者取对应乳腺容积活检。
- 6个恶性病灶中3个超声隐匿、3个仅表现为细微低回声改变。
核心结论
- MRI与实时超声配准使仅MRI检出的乳腺病灶得以超声定位,VNT是超声隐匿性乳腺病灶MRI引导活检的可行替代方案。
研究设计与样本
- 单臂可行性研究,招募期13个月(2014年1月1日至2015年2月1日),纳入22例患者26个BI-RADS 4或5类病灶,均为MRI检出而二次超声未发现。
- 采用3-T MRI扫描仪、快速序列和柔性体线圈重新成像,患者仰卧位,乳腺放置三个皮肤标记。
- MRI容积数据在专用平台与实时超声配准,对6个肿块、11个非肿块强化、8个焦点和1个结构扭曲行VNT引导超声寻找。
- 对超声可检出的11个病灶各取5份针刺活检标本,对仍超声隐匿的15个病灶取对应MRI病灶的乳腺容积标本。
关键影像表现/征象
- 26个病灶中6个为肿块、11个为非肿块强化、8个为焦点、1个为结构扭曲。
- 6个恶性病灶中1个为肿块、3个为非肿块强化、2个为强化焦点;3个超声隐匿,3个仅见细微低回声改变。
- 良性病灶均未在超声上显示为肿块,随访期间无一进展,56%在随访MRI消失(平均随访14个月)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess the utility of a volume navigation technique (VNT) for ultrasound-guided biopsy of MRI-detected, but sonographically ambiguous or occult, breast lesions.
SUBJECTS AND METHODS: Within a recruitment period of 13 months (January 1, 2014, through February 1, 2015), 22 patients with 26 BI-RADS category 4 or 5 lesions that were detected at MRI but missed at second-look ultrasound were reimaged using a rapid sequence and a flexible body coil in a 3-T MRI scanner. Patients were supine, with three skin markers placed on the breasts. MRI volume data were coregistered to real-time ultrasound in a dedicated platform, and MRI-detected lesions (six masses, 11 nonmass enhancements, eight foci, and one architectural distortion) were sought using VNT-guided ultrasound. Five needle biopsy specimens were obtained either from each sonographically detected lesion (n = 11) or from VNT-guided sonographically localized breast volume corresponding to the MRI-detected, but still ultrasound-occult, lesions (n = 15).
RESULTS: Histopathologic analysis revealed 18 benign and six malignant lesions. The remaining two lesions, both of which appeared as masses at MRI, were high risk and were upgraded to carcinoma after excisional biopsy. All malignant lesions underwent curative surgery; the final histopathologic diagnoses remained unchanged. Of the six malignant lesions, one was a mass, three were nonmass enhancements, and two were enhancing foci at MRI. Three malignant lesions were occult at ultrasound, and three were discerned as subtle hypoechoic changes. No benign lesion was sonographically visualized as a mass, and none progressed, with 56% disappearing at MRI performed during the follow-up period (mean, 14 months).
CONCLUSION: Coregistration of MRI and real-time ultrasound enables sonographic localization of breast lesions detected at MRI only. VNT is a feasible alternative to MRI-guided biopsy of ultrasound-occult breast lesions.
引用
- Aribal E, Tureli D, Kucukkaya F, et al. Volume Navigation Technique for Ultrasound-Guided Biopsy of Breast Lesions Detected Only at MRI. AJR Am J Roentgenol. 2017. PMID: 28267361. doi:10.2214/AJR.16.16808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。